海峽股份(002320.SZ):新海港一期重組配套募集資金項目結項 節餘募集資金永久補充流動資金
格隆匯9月17日丨海峽股份(002320.SZ)公佈,鑑於公司向海南港航控股有限公司(以下簡稱“海南港航”)發行股份購買新海港一期並募集配套資金項目已實施完畢,為充分發揮節餘募集資金的使用效率,擬將募集資金存儲專户實際餘額(截至2020年6月30日)1425.01萬元及後期利息收入,約佔募集資金淨額的32.89%,轉入自有資金賬户用於永久補充流動資金,並註銷相關募集資金專項賬户。受審批日至實施日利息收入的影響,具體補充流動資金的金額以轉入自有資金賬户實際金額合計數為準。該事項尚需提交股東大會審議通過後方可實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.